TENET HEALTHCARE CORP (THC)
Healthcare › Services-General Medical & Surgical Hospitals, NEC
Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- Trading 50% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 5/9 — moderate financial health
- ROE of 57.0% — good return on equity
TENET HEALTHCARE CORP (THC) is a Healthcare company operating in Services-General Medical & Surgical Hospitals, NEC, listed on the NYSE , with a market capitalisation of $17.4 billion . Key value metrics: P/E ratio 11.6, P/B ratio 4.93, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
TENET HEALTHCARE CORP — Fundamental Analysis Summary
TENET HEALTHCARE CORP (THC) is currently trading 50% above its Graham Number of $133.36, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries a low trailing P/E ratio of 11.6x.
On financial health, THC shows a moderate Piotroski F-Score of 5/9, and strong return on equity of 57.0% (sector average: -19.8%), and high leverage with a debt-to-equity ratio of 3.12.
StockPik's composite Value Score for THC is 73/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
THC shows revenue growing at 3% year-over-year, with earnings declining at 56%.